ArticleNeuroscience letters2019
Potency, efficacy, and selectivity of GR64349 at human recombinant neurokinin NK2 and NK1 receptors.
Elisabetta Perdona et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it